Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
CA 2277022 A1 · Owner: Keystone Biomedical, Inc. · Inventors: Horwitz, Lawrence D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for the treatment of atherosclerosis and vascular injury using exochelins, and more particularly exochelins of Mycobacterium tuberculosis to , prevent vascular smooth muscle cell proliferation. Delivery of an effective amount of a desferri-Exochelins to a living organism such as an animal or a human by oral, intravenous or direct delivery to the site at which the effect is desired will protect blood vessels in a living organism from restenosis following angioplasty or vascular surgery and will prevent or slow the progression of atherosclerosis, systemic hypertension radiation damage to the , vasculature, stenosis or closure of bypass grafts to the coronary arteries or other …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 6, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 6, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 6, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.